1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Molecular Microbial Persistence and Pathogenesis (T32 Training Grant) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This is a pre- and post-doctoral training grant focused on molecular microbial persistence and pathogenesis. It provides financial support for graduate students, including a competitive stipend, full tuition remission, and individual health insurance.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Molecular Microbial Persistence and Pathogenesis - Neal Deluca Molecular Microbial Persistence and Pathogenesis University of Pittsburgh, Pittsburgh, PA, United States Search grants from University of Pittsburgh Biochemical and pharmacological studies of human membrane progesterone receptors Inbre:Upr-Rpc: DNA Sequencing and Multi-Locus Genotyping Facilities Bioengineering Design of Artificial Blood Adenovirus in Bronchioloalveolar Cell Lung Carcinoma Mucin Glycoproteins in Colon Cancer Metastasis Shared Resource 13: Health Communication Hormonal Regulation and Tumor Promotional Phenotypes of Semaphorin 7a in Breast Cancer Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer Shared Resource 14: Survey and Data Management Investigating the Role of Adipocyte Lipolysis in Melanoma Progression Infectious diseases remains the leading cause of death worldwide, and the necessity to markedly increase training in infectious diseases has been highlighted by the emergence of new pathogens and the threat of bioterrorism.
The complexity and diversity of persistence and pathogenesis mechanisms utilized by microorganisms pose major challenges to the development of effective vaccines to prevent infection and chemical or immune-based treatments of infectious diseases.
Research into microbial persistence and pathogenesis requires, in addition to broad training in microbiology, expertise in molecular genetics, biochemistry, immunology, and cell and molecular biology. Thus, there continues to be an urgent need to train a new generation of independent investigators with the interdisciplinary experience and expertise to address these complex issues of persistence and pathogenesis.
A goal of the training program has been, and will continue to be, the recruitment of undergraduates and recent Ph. D. graduates in related disciplines (biochemistry, biological sciences, cellular and molecular biology, etc) into advanced studies in mechanisms of microbial persistence and pathogenesis.
The training program brings together faculty throughout the University of Pittsburgh, including the School of Medicine, Graduate School of Public Health, and the Faculty of Arts and Sciences.
The Molecular Microbial Persistence and Pathogenesis (MMPP) training program offers a unique opportunity for the coordinated interdisciplinary research training of predoctoral trainees within the structur of the Molecular Virology and Microbiology (MVM) Graduate Program and postdoctoral trainees within the laboratories of MMPP faculty, with additional training via specialized course offerings, dedicated research seminars, retreats, and participation in national scientific meetings.
Importantly, the MMPP program is unique in that it leverages concepts in persistence and pathogenesis from diverse viral and bacterial systems with the goal of educating trainees of the diversity of microbial mechanisms, but also enabling the utilization of common themes for their research. Support for 4 predoctoral and 2 postdoctoral trainees per year is requested. Predoctoral trainees can be appointed for up to two years.
Postdoctoral trainees are appointed for 1 year with the opportunity to competitively renew their appointments for an additional year. The MMPP program remains committed to the need to increase diversity in trainees, to provide training in the responsible conduct of research, and to provide career guidance for trainees.
Infectious diseases remains the leading cause of death worldwide, and the necessity to markedly increase training in infectious diseases has been highlighted by the emergence of new pathogens and the threat of bioterrorism.
The complexity and diversity of persistence and pathogenesis mechanisms utilized by microorganisms pose major challenges to the development of effective vaccines to prevent infection and chemical or immune-based treatments of infectious diseases. A goal of the training program is the recruitment of undergraduates and recent Ph. D.
graduates in related disciplines (biochemistry, biological sciences, cellular and molecular biology, etc) into advanced studies in mechanisms of microbial persistence and pathogenesis.
Agency National Institute of Health (NIH) Institute National Institute of Allergy and Infectious Diseases (NIAID) Type Institutional National Research Service Award (T32) Project # 2T32AI049820-11A1 Study Section Microbiology and Infectious Diseases Research Committee (MID) Program Officer Robbins, Christiane M Name University of Pittsburgh Department Internal Medicine/Medicine Wasil, Laura R; Shair, Kathy H Y (2018) Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.
J Virol 92: Ander, Stephanie E; Rudzki, Elizabeth N; Arora, Nitin et al. (2018) Human Placental Syncytiotrophoblasts Restrict Toxoplasma gondii Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines. MBio 9: Lane, Whitney C; Dunn, Matthew D; Gardner, Christina L et al.
(2018) The Efficacy of the Interferon Alpha/Beta Response versus Arboviruses Is Temperature Dependent. MBio 9: Bina, X Renee; Howard, Mondraya F; Taylor-Mulneix, Dawn L et al. (2018) The Vibrio cholerae RND efflux systems impact virulence factor production and adaptive responses via periplasmic sensor proteins.
PLoS Pathog 14:e1006804 Kiedrowski, Megan R; Gaston, Jordan R; Kocak, Brian R et al. (2018) Staphylococcus aureus Biofilm Growth on Cystic Fibrosis Airway Epithelial Cells Is Enhanced during Respiratory Syncytial Virus Coinfection. mSphere 3: Purcaro, Giorgia; Rees, Christiaan A; Melvin, Jeffrey A et al.
(2018) Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model. J Breath Res 12:046001 Fox, Hannah L; Dembowski, Jill A; DeLuca, Neal A (2017) A Herpesviral Immediate Early Protein Promotes Transcription Elongation of Viral Transcripts.
MBio 8: Kunkle, Dillon E; Bina, X Renee; Bina, James E (2017) The Vibrio cholerae VexGH RND Efflux System Maintains Cellular Homeostasis by Effluxing Vibriobactin. MBio 8: Kwun, H J; Wendzicki, J A; Shuda, Y et al. (2017) Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting.
Oncogene 36:6784-6792 Treat, Benjamin R; Bidula, Sarah M; Ramachandran, Srividya et al. (2017) Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells. PLoS Pathog 13:e1006732 Showing the most recent 10 out of 84 publications Be the first to comment on Neal Deluca's grant
According to the current listing, eligibility includes: Pre- and post-doctoral trainees within the Program of Microbiology and Immunology at the University of Pittsburgh School of Medicine. Confirm the full requirements in the official notice before applying.
Molecular Microbial Persistence and Pathogenesis (T32 Training Grant) is funded by National Institute of Allergy and Infectious Diseases (NIAID), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
National Institute of Allergy and Infectious Diseases (NIAID) Resource-Related Research Projects (R24 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This program supports resource development projects to advance infectious disease and immunology research, aligning with NIAID's vision to improve human health through an integrated approach to infectious and immune-mediated disease research.
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This funding opportunity supports investigator-initiated clinical trials requiring enhanced oversight, with durations up to 7 years, relevant to the NIAID mission of improving human health through infectious and immune-mediated disease research.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article